BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9638373)

  • 1. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation.
    Gerondakis S; Grumont R; Rourke I; Grossmann M
    Curr Opin Immunol; 1998 Jun; 10(3):353-9. PubMed ID: 9638373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Rel/NF-kappa-B transcription factors: complex role in cell regulation].
    Bottex-Gauthier C; Pollet S; Favier A; Vidal DR
    Pathol Biol (Paris); 2002 Apr; 50(3):204-11. PubMed ID: 11980335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-kappa B proteins.
    Patra AK; Na SY; Bommhardt U
    J Immunol; 2004 Apr; 172(8):4812-20. PubMed ID: 15067058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.
    Grumont RJ; Rourke IJ; O'Reilly LA; Strasser A; Miyake K; Sha W; Gerondakis S
    J Exp Med; 1998 Mar; 187(5):663-74. PubMed ID: 9480976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF kappa B/I kappa B proteins. Their role in cell growth, differentiation and development. Madrid, Spain, July 7-10, 1996.
    Siebenlist U
    Biochim Biophys Acta; 1997 Feb; 1332(1):R7-13. PubMed ID: 9061013
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development.
    Sivakumar V; Hammond KJ; Howells N; Pfeffer K; Weih F
    J Exp Med; 2003 Jun; 197(12):1613-21. PubMed ID: 12810684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice.
    Attar RM; Caamaño J; Carrasco D; Iotsova V; Ishikawa H; Ryseck RP; Weih F; Bravo R
    Semin Cancer Biol; 1997 Apr; 8(2):93-101. PubMed ID: 9299587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Mercurio F; DiDonato JA; Rosette C; Karin M
    Genes Dev; 1993 Apr; 7(4):705-18. PubMed ID: 8458581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts.
    Gerondakis S; Grossmann M; Nakamura Y; Pohl T; Grumont R
    Oncogene; 1999 Nov; 18(49):6888-95. PubMed ID: 10602464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.
    Mattioli I; Sebald A; Bucher C; Charles RP; Nakano H; Doi T; Kracht M; Schmitz ML
    J Immunol; 2004 May; 172(10):6336-44. PubMed ID: 15128824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
    Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
    Zelazowski P; Shen Y; Snapper CM
    Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
    Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
    J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50.
    Phi van L
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):39-44. PubMed ID: 8546707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
    Weih F; Carrasco D; Bravo R
    Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.
    Köntgen F; Grumont RJ; Strasser A; Metcalf D; Li R; Tarlinton D; Gerondakis S
    Genes Dev; 1995 Aug; 9(16):1965-77. PubMed ID: 7649478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of type I diabetes by NF-kappa B.
    Lamhamedi-Cherradi SE; Zheng S; Hilliard BA; Xu L; Sun J; Alsheadat S; Liou HC; Chen YH
    J Immunol; 2003 Nov; 171(9):4886-92. PubMed ID: 14568969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rel/NF-kappaB transcription factors: key mediators of B-cell activation.
    Gugasyan R; Grumont R; Grossmann M; Nakamura Y; Pohl T; Nesic D; Gerondakis S
    Immunol Rev; 2000 Aug; 176():134-40. PubMed ID: 11043773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.